Sodium-retaining effect of insulin in diabetes
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Insulin has long been hypothesized to cause sodium retention, potentially of enough magnitude to contribute to hypertension in obesity, metabolic syndrome, and Type II diabetes. There is an abundance of supportive evidence from correlational analyses in humans, acute insulin infusion studies in humans and animals, and chronic insulin infusion studies in rats. However, the absence of hypertension in human insulinoma patients, and negative results for sodium-retaining or blood pressure effects of chronic insulin infusion in a whole series of dog studies, strongly refute the insulin hypothesis. We recently questioned whether the euglycemic, hyperinsulinemia model used for most insulin infusion studies, including the previous chronic dog studies, was the most appropriate model to test the renal actions of insulin in obesity, metabolic syndrome, and Type II diabetes. In those circumstances, hyperinsulinemia coexists with hyperglycemia. Therefore, we tested the sodium-retaining effect of insulin in chronically instrumented, alloxan-treated diabetic dogs. We used 24 h/day intravenous insulin infusion to regulate plasma insulin concentration. Induction of diabetes (∼400 mg/dl) caused sustained natriuresis and diuresis. However, if we clamped insulin at baseline, control levels, i.e., prevented it from decreasing, then the sustained natriuresis and diuresis were completely reversed, despite the same level of hyperglycemia. We also found that 24 h/day intrarenal insulin infusion had the same effect in diabetic dogs but had no sodium-retaining action in normal dogs. This new evidence that insulin has a sodium-retaining effect during hyperglycemia may have implications for maintaining sodium balance in uncontrolled Type II diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Insulin and Glucose Infusions on Sympathetic Nervous System Activity in Normal Man
Rowe, J. W., Young, J. B., Minaker, K. L., Stevens, A. L., Pallotta, J., & Landsberg, L. (1981) · Diabetes · doi:10.2337/diab.30.3.219 · Cited by 1,143 · cited 1×
“There also was evidence that insulin could activate the sympathetic nervous system (3, 59, 70, 78), which suggested an indirect effect on blood pressure through neural control of the kidneys and systemic vasculature.”
Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.
Anderson, E. A., Hoffman, R. P., Balon, T. W., Sinkey, C. A., & Mark, A. L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115260 · Cited by 1,075 · cited 1×
“There also was evidence that insulin could activate the sympathetic nervous system (3, 59, 70, 78), which suggested an indirect effect on blood pressure through neural control of the kidneys and systemic vasculature.”
(Patho)physiological Significance of the Serum- and Glucocorticoid-Inducible Kinase Isoforms
Lang, F., Böhmer, C., Palmada, M., Seebohm, G., Strutz-Seebohm, N., & Vallon, V. (2006) · Physiological Reviews · doi:10.1152/physrev.00050.2005 · Cited by 689 · cited 1×
“We have no experimental evidence that the well-known effect of glucose to stimulate SGLT in diabetes (64, 94) is amplified in the presence of insulin, but serum and glucocorticoid-inducible kinase 1 (SGK1) has been shown to regulate proximal tubular glucose transport (1) and to be stimulated by glucose (1, 45, 79) and…”
Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects.
Kolterman, O. G., Insel, J., Saekow, M., & Olefsky, J. M. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109790 · Cited by 664
Metabolic Syndrome and Kidney Disease: A Systematic Review and Meta-analysis
Thomas, G., Sehgal, A. R., Kashyap, S. R., Srinivas, T. R., Kirwan, J. P., & Navaneethan, S. D. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02180311 · Cited by 553 · cited 1×
“Hypertensive subjects with obesity and metabolic syndrome are hyperglycemic and hyperinsulinemic (8, 35, 56, 63, 88).”
Obesity-induced Hypertension: Role of Sympathetic Nervous System, Leptin, and Melanocortins
Hall, J. E., da Silva, A. A., do Carmo, J. M., Dubinion, J., Hamza, S., Munusamy, S., Smith, G., & Stec, D. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.113175 · Cited by 528 · cited 2×
“Many laboratories, in fact, are pursuing exciting new mechanisms besides insulin to explain hypertension in metabolic syndrome and obesity (21, 42, 56, 74).”
Putnam, K., Shoemaker, R., Yiannikouris, F., & Cassis, L. A. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00796.2011 · Cited by 273
Pathogenesis and pathophysiology of the cardiometabolic syndrome
Kirk, E. P., & Klein, S. (2009) · The Journal of Clinical Hypertension · doi:10.1111/j.1559-4572.2009.00054.x · Cited by 195 · cited 2×
“From these data, it is surprising that insulin continues to be discussed as a contributing factor for sodium retention and hypertension in obesity or metabolic syndrome in humans (53, 77, 80).”
Ward, K. R., Bardgett, J. F., Wolfgang, L., & Stocker, S. D. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.160671 · Cited by 118 · cited 1×
“There also has been continued support for an effect of insulin to stimulate the sympathetic nervous system (6, 67, 68, 96).”
Chronic hyperinsulinemia and blood pressure. Interaction with catecholamines?
Hall, J. E., Brands, M. W., Kivlighn, S. D., Mizelle, H. L., Hildebrandt, D. A., & Gaillard, C. A. (1990) · Hypertension · doi:10.1161/01.hyp.15.5.519 · Cited by 116
Self-citation
Cited by
The impact of insulin resistance on the kidney and vasculature
Artunc, F., Schleicher, E., Weigert, C., Fritsche, A., Stefan, N., & Häring, H.-U. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.145 · Cited by 462
Hyperinsulinemia: An Early Indicator of Metabolic Dysfunction
Thomas, D. D., Corkey, B. E., Istfan, N. W., & Apovian, C. M. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00065 · Cited by 259
Cherney, D. Z. I., Cooper, M. E., Tikkanen, I., Pfarr, E., Johansen, O. E., Woerle, H. J., Broedl, U. C., & Lund, S. S. (2018) · Kidney International · doi:10.1016/j.kint.2017.06.017 · Cited by 243
The metabolic syndrome and chronic kidney disease
Zhang, X., & Lerman, L. O. (2017) · Translational Research · doi:10.1016/j.trsl.2016.12.004 · Cited by 173
“Furthermore, when coexisting with hyperglycemia, insulin exhibits antinatriuretic effect by promoting sodium retention.(133) As proximal tubular epithelial cells often undergo hypertrophy in obese subjects,(134) together they may account for increased sodium reabsorption and elevation of arterial pressure.”
Sjöström, C. D., Johansson, P., Ptaszynska, A., List, J., & Johnsson, E. (2015) · Diabetes and Vascular Disease Research · doi:10.1177/1479164115585298 · Cited by 97
Metadata
- Authors
- Brands, M. W., & Manhiani, M. M.
- Venue
- American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Publisher
- American Physiological Society
- Published
- 2012-12-01
- Volume
- 303
- Issue
- 11
- Pages
- R1101-R1109
- ISSN
- 0363-6119 (ISSN-L)
- 1522-1490
- OpenAlex
- W2089231924
- Cited by
- 73
- References
- 12
- FWCI
- 0.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sodium-retaining effect of insulin in diabetes. https://app.cochat.ai/papers/10.1152/ajpregu.00390.2012
- The paper
- Brands, M. W., & Manhiani, M. M. (2012). Sodium-retaining effect of insulin in diabetes. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. https://doi.org/10.1152/ajpregu.00390.2012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.